$RDYN Insider Trading
FREE EMAIL WATCHDOG
Get free email notifications about insider trading in Cardiovascular Systems Inc.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insiders | Insider Transactions | Monthly Overview | Weekly Overview
Overview of all insider trading transactions in Cardiovascular Systems Inc. Get notifications about new insider transactions in Cardiovascular Systems Inc for free.
Page: < prev 1 ... 2 3 4 5 6 7 8 9 9 next >
Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
---|---|---|---|---|---|---|---|---|---|---|---|
Jan 07 2013 | RDYN | Cardiovascular Sys ... | NELSON GLEN D | Director | Buy | P | 11.75 | 6,724 | 79,007 | 420,916 | 414.2 K to 420.9 K (+1.62 %) |
Jan 07 2013 | RDYN | Cardiovascular Sys ... | NELSON GLEN D | Director | Buy | P | 11.97 | 5,500 | 65,835 | 414,192 | 408.7 K to 414.2 K (+1.35 %) |
Jan 07 2013 | RDYN | Cardiovascular Sys ... | NELSON GLEN D | Director | Buy | P | 12.09 | 15,000 | 181,350 | 408,692 | 393.7 K to 408.7 K (+3.81 %) |
Dec 04 2012 | RDYN | Cardiovascular Sys ... | Koehn Paul A | VP Quality & Operat ... | Sell | S | 11.60 | 5,000 | 57,991 | 55,227 | 60.2 K to 55.2 K (-8.30 %) |
Nov 29 2012 | RDYN | Cardiovascular Sys ... | Martin David | President and CEO | Sell | S | 11.67 | 1,800 | 21,006 | 350,168 | 352 K to 350.2 K (-0.51 %) |
Nov 29 2012 | RDYN | Cardiovascular Sys ... | Martin David | President and CEO | Sell | S | 11.54 | 1,800 | 20,772 | 351,968 | 353.8 K to 352 K (-0.51 %) |
Nov 20 2012 | RDYN | Cardiovascular Sys ... | Kenny Kevin J | Exec. VP, Sales & M ... | Sell | S | 10.68 | 278 | 2,969 | 102,519 | 102.8 K to 102.5 K (-0.27 %) |
Nov 15 2012 | RDYN | Cardiovascular Sys ... | Kenny Kevin J | Exec. VP, Sales & M ... | Sell | S | 11.22 | 3,038 | 34,086 | 102,797 | 105.8 K to 102.8 K (-2.87 %) |
Nov 02 2012 | RDYN | Cardiovascular Sys ... | Flaherty James E | Chief Administrativ ... | Sell | S | 12.00 | 10,000 | 120,000 | 135,736 | 145.7 K to 135.7 K (-6.86 %) |
Oct 01 2012 | RDYN | Cardiovascular Sys ... | Koehn Paul A | VP Quality & Operat ... | Sell | S | 11.49 | 7,203 | 82,736 | 60,227 | 67.4 K to 60.2 K (-10.68 %) |
Sep 05 2012 | RDYN | Cardiovascular Sys ... | Trigg Leslie | Director | Option Exercise | A | 0.00 | 10,917 | 0 | 10,917 | |
Sep 05 2012 | RDYN | Cardiovascular Sys ... | Trigg Leslie | Director | Grant | A | 0.00 | 6,550 | 0 | 14,146 | 20.7 K to 14.1 K (-31.65 %) |
Sep 05 2012 | RDYN | Cardiovascular Sys ... | NELSON GLEN D | Director | Option Exercise | A | 0.00 | 10,917 | 0 | 10,917 | |
Sep 05 2012 | RDYN | Cardiovascular Sys ... | NELSON GLEN D | Director | Grant | A | 0.00 | 10,917 | 0 | 393,692 | 382.8 K to 393.7 K (+2.85 %) |
Sep 05 2012 | RDYN | Cardiovascular Sys ... | Martin David | President and CEO | Sell | S | 9.07 | 1,100 | 9,972 | 353,768 | 354.9 K to 353.8 K (-0.31 %) |
Sep 05 2012 | RDYN | Cardiovascular Sys ... | LAWLOR AUGUSTINE | Director | Option Exercise | A | 0.00 | 10,917 | 0 | 10,917 | |
Sep 05 2012 | RDYN | Cardiovascular Sys ... | LAWLOR AUGUSTINE | Director | Grant | A | 0.00 | 5,459 | 0 | 9,055 | 3.6 K to 9.1 K (+151.81 %) |
Sep 05 2012 | RDYN | Cardiovascular Sys ... | FRIEDMAN JOHN H | Director | Option Exercise | A | 0.00 | 10,917 | 0 | 10,917 | |
Sep 05 2012 | RDYN | Cardiovascular Sys ... | Brown Edward M | Director | Option Exercise | A | 0.00 | 10,917 | 0 | 10,917 | |
Sep 05 2012 | RDYN | Cardiovascular Sys ... | Brown Edward M | Director | Grant | A | 0.00 | 7,642 | 0 | 77,744 | 70.1 K to 77.7 K (+10.90 %) |
Sep 05 2012 | RDYN | Cardiovascular Sys ... | Blackey Brent G | Director | Option Exercise | A | 0.00 | 10,917 | 0 | 10,917 | |
Sep 05 2012 | RDYN | Cardiovascular Sys ... | Blackey Brent G | Director | Grant | A | 0.00 | 6,550 | 0 | 23,753 | 17.2 K to 23.8 K (+38.07 %) |
Aug 28 2012 | RDYN | Cardiovascular Sys ... | Thatcher Robert J | Executive VP | Sell | S | 9.03 | 287 | 2,591 | 125,447 | 125.7 K to 125.4 K (-0.23 %) |
Aug 28 2012 | RDYN | Cardiovascular Sys ... | Koehn Paul A | VP Quality & Operat ... | Sell | S | 9.03 | 220 | 1,986 | 67,430 | 67.7 K to 67.4 K (-0.33 %) |
Aug 28 2012 | RDYN | Cardiovascular Sys ... | Martin David | President and CEO | Gift | G | 0.00 | 1,400 | 0 | 1,400 | 0 to 1.4 K |
Aug 28 2012 | RDYN | Cardiovascular Sys ... | Martin David | President and CEO | Gift | G | 0.00 | 1,400 | 0 | 1,400 | 0 to 1.4 K |
Aug 28 2012 | RDYN | Cardiovascular Sys ... | Martin David | President and CEO | Gift | G | 0.00 | 1,400 | 0 | 1,400 | 0 to 1.4 K |
Aug 28 2012 | RDYN | Cardiovascular Sys ... | Martin David | President and CEO | Gift | G | 0.00 | 4,200 | 0 | 354,868 | 359.1 K to 354.9 K (-1.17 %) |
Aug 28 2012 | RDYN | Cardiovascular Sys ... | Martin David | President and CEO | Sell | S | 9.03 | 862 | 7,784 | 359,068 | 359.9 K to 359.1 K (-0.24 %) |
Aug 28 2012 | RDYN | Cardiovascular Sys ... | Kenny Kevin J | Exec. VP, Sales & M ... | Sell | S | 9.03 | 75 | 677 | 105,835 | 105.9 K to 105.8 K (-0.07 %) |
Aug 28 2012 | RDYN | Cardiovascular Sys ... | Flaherty James E | Chief Administrativ ... | Sell | S | 9.03 | 353 | 3,187 | 145,736 | 146.1 K to 145.7 K (-0.24 %) |
Aug 23 2012 | RDYN | Cardiovascular Sys ... | Thatcher Robert J | Executive VP | Sell | S | 8.90 | 1,151 | 10,241 | 125,734 | 126.9 K to 125.7 K (-0.91 %) |
Aug 23 2012 | RDYN | Cardiovascular Sys ... | Thatcher Robert J | Executive VP | Sell | S | 9.02 | 310 | 2,798 | 126,885 | 127.2 K to 126.9 K (-0.24 %) |
Aug 23 2012 | RDYN | Cardiovascular Sys ... | Thatcher Robert J | Executive VP | Sell | S | 9.19 | 1,828 | 16,801 | 127,195 | 129 K to 127.2 K (-1.42 %) |
Aug 28 2012 | RDYN | Cardiovascular Sys ... | BETTERLEY LAURENCE L | Chief Financial Off ... | Sell | S | 9.03 | 416 | 3,756 | 199,909 | 200.3 K to 199.9 K (-0.21 %) |
Aug 23 2012 | RDYN | Cardiovascular Sys ... | Martin David | President and CEO | Sell | S | 8.90 | 3,674 | 32,689 | 359,930 | 363.6 K to 359.9 K (-1.01 %) |
Aug 23 2012 | RDYN | Cardiovascular Sys ... | Martin David | President and CEO | Sell | S | 9.02 | 990 | 8,934 | 363,604 | 364.6 K to 363.6 K (-0.27 %) |
Aug 23 2012 | RDYN | Cardiovascular Sys ... | Martin David | President and CEO | Sell | S | 9.19 | 5,846 | 53,730 | 364,594 | 370.4 K to 364.6 K (-1.58 %) |
Aug 23 2012 | RDYN | Cardiovascular Sys ... | Koehn Paul A | VP Quality & Operat ... | Sell | S | 8.90 | 874 | 7,776 | 67,650 | 68.5 K to 67.7 K (-1.28 %) |
Aug 23 2012 | RDYN | Cardiovascular Sys ... | Koehn Paul A | VP Quality & Operat ... | Sell | S | 9.02 | 235 | 2,121 | 68,524 | 68.8 K to 68.5 K (-0.34 %) |
Aug 23 2012 | RDYN | Cardiovascular Sys ... | Koehn Paul A | VP Quality & Operat ... | Sell | S | 9.19 | 1,387 | 12,748 | 68,759 | 70.1 K to 68.8 K (-1.98 %) |
Aug 23 2012 | RDYN | Cardiovascular Sys ... | Kenny Kevin J | Exec. VP, Sales & M ... | Sell | S | 8.90 | 286 | 2,545 | 105,910 | 106.2 K to 105.9 K (-0.27 %) |
Aug 23 2012 | RDYN | Cardiovascular Sys ... | Kenny Kevin J | Exec. VP, Sales & M ... | Sell | S | 9.02 | 77 | 695 | 106,196 | 106.3 K to 106.2 K (-0.07 %) |
Aug 23 2012 | RDYN | Cardiovascular Sys ... | Kenny Kevin J | Exec. VP, Sales & M ... | Sell | S | 9.19 | 454 | 4,173 | 106,273 | 106.7 K to 106.3 K (-0.43 %) |
Aug 23 2012 | RDYN | Cardiovascular Sys ... | Flaherty James E | Chief Administrativ ... | Sell | S | 8.90 | 1,407 | 12,519 | 146,089 | 147.5 K to 146.1 K (-0.95 %) |
Aug 23 2012 | RDYN | Cardiovascular Sys ... | Flaherty James E | Chief Administrativ ... | Sell | S | 9.02 | 378 | 3,411 | 147,496 | 147.9 K to 147.5 K (-0.26 %) |
Aug 23 2012 | RDYN | Cardiovascular Sys ... | Flaherty James E | Chief Administrativ ... | Sell | S | 9.19 | 2,233 | 20,523 | 147,874 | 150.1 K to 147.9 K (-1.49 %) |
Aug 20 2012 | RDYN | Cardiovascular Sys ... | Thatcher Robert J | Executive VP | Sell | S | 8.97 | 1,346 | 12,075 | 129,023 | 130.4 K to 129 K (-1.03 %) |
Aug 20 2012 | RDYN | Cardiovascular Sys ... | Thatcher Robert J | Executive VP | Sell | S | 8.75 | 1,392 | 12,181 | 130,369 | 131.8 K to 130.4 K (-1.06 %) |
Aug 20 2012 | RDYN | Cardiovascular Sys ... | Thatcher Robert J | Executive VP | Sell | S | 8.73 | 1,197 | 10,449 | 131,761 | 133 K to 131.8 K (-0.90 %) |
Aug 20 2012 | RDYN | Cardiovascular Sys ... | Martin David | President and CEO | Sell | S | 8.97 | 4,304 | 38,611 | 370,440 | 374.7 K to 370.4 K (-1.15 %) |
Aug 20 2012 | RDYN | Cardiovascular Sys ... | Martin David | President and CEO | Sell | S | 8.75 | 4,451 | 38,949 | 374,744 | 379.2 K to 374.7 K (-1.17 %) |
Aug 20 2012 | RDYN | Cardiovascular Sys ... | Martin David | President and CEO | Sell | S | 8.73 | 3,827 | 33,408 | 379,195 | 383 K to 379.2 K (-1.00 %) |
Aug 23 2012 | RDYN | Cardiovascular Sys ... | BETTERLEY LAURENCE L | Chief Financial Off ... | Sell | S | 8.90 | 1,671 | 14,867 | 200,325 | 202 K to 200.3 K (-0.83 %) |
Aug 23 2012 | RDYN | Cardiovascular Sys ... | BETTERLEY LAURENCE L | Chief Financial Off ... | Sell | S | 9.02 | 449 | 4,052 | 201,996 | 202.4 K to 202 K (-0.22 %) |
Aug 23 2012 | RDYN | Cardiovascular Sys ... | BETTERLEY LAURENCE L | Chief Financial Off ... | Sell | S | 9.19 | 2,650 | 24,356 | 202,445 | 205.1 K to 202.4 K (-1.29 %) |
Aug 20 2012 | RDYN | Cardiovascular Sys ... | Koehn Paul A | VP Quality & Operat ... | Sell | S | 8.97 | 1,022 | 9,168 | 70,146 | 71.2 K to 70.1 K (-1.44 %) |
Aug 20 2012 | RDYN | Cardiovascular Sys ... | Koehn Paul A | VP Quality & Operat ... | Sell | S | 8.75 | 1,057 | 9,249 | 71,168 | 72.2 K to 71.2 K (-1.46 %) |
Aug 20 2012 | RDYN | Cardiovascular Sys ... | Koehn Paul A | VP Quality & Operat ... | Sell | S | 8.73 | 909 | 7,935 | 72,225 | 73.1 K to 72.2 K (-1.24 %) |
Aug 20 2012 | RDYN | Cardiovascular Sys ... | Kenny Kevin J | Exec. VP, Sales & M ... | Sell | S | 8.97 | 334 | 2,996 | 106,727 | 107.1 K to 106.7 K (-0.31 %) |
Aug 20 2012 | RDYN | Cardiovascular Sys ... | Kenny Kevin J | Exec. VP, Sales & M ... | Sell | S | 8.75 | 346 | 3,028 | 107,061 | 107.4 K to 107.1 K (-0.32 %) |
Aug 20 2012 | RDYN | Cardiovascular Sys ... | Kenny Kevin J | Exec. VP, Sales & M ... | Sell | S | 8.73 | 297 | 2,593 | 107,407 | 107.7 K to 107.4 K (-0.28 %) |
Aug 20 2012 | RDYN | Cardiovascular Sys ... | Flaherty James E | Chief Administrativ ... | Sell | S | 8.97 | 1,645 | 14,757 | 150,107 | 151.8 K to 150.1 K (-1.08 %) |
Aug 20 2012 | RDYN | Cardiovascular Sys ... | Flaherty James E | Chief Administrativ ... | Sell | S | 8.75 | 1,701 | 14,885 | 151,752 | 153.5 K to 151.8 K (-1.11 %) |
Aug 20 2012 | RDYN | Cardiovascular Sys ... | Flaherty James E | Chief Administrativ ... | Sell | S | 8.73 | 1,462 | 12,763 | 153,453 | 154.9 K to 153.5 K (-0.94 %) |
Aug 20 2012 | RDYN | Cardiovascular Sys ... | BETTERLEY LAURENCE L | Chief Financial Off ... | Sell | S | 8.97 | 1,951 | 17,502 | 205,095 | 207 K to 205.1 K (-0.94 %) |
Aug 20 2012 | RDYN | Cardiovascular Sys ... | BETTERLEY LAURENCE L | Chief Financial Off ... | Sell | S | 8.75 | 2,018 | 17,659 | 207,046 | 209.1 K to 207 K (-0.97 %) |
Aug 20 2012 | RDYN | Cardiovascular Sys ... | BETTERLEY LAURENCE L | Chief Financial Off ... | Sell | S | 8.73 | 1,735 | 15,146 | 209,064 | 210.8 K to 209.1 K (-0.82 %) |
Aug 15 2012 | RDYN | Cardiovascular Sys ... | BETTERLEY LAURENCE L | Chief Financial Off ... | Sell | S | 8.92 | 1,507 | 13,439 | 210,799 | 212.3 K to 210.8 K (-0.71 %) |
Aug 15 2012 | RDYN | Cardiovascular Sys ... | BETTERLEY LAURENCE L | Chief Financial Off ... | Grant | A | 0.00 | 26,290 | 0 | 212,306 | 186 K to 212.3 K (+14.13 %) |
Aug 15 2012 | RDYN | Cardiovascular Sys ... | BETTERLEY LAURENCE L | Chief Financial Off ... | Grant | A | 0.00 | 13,145 | 0 | 186,016 | 172.9 K to 186 K (+7.60 %) |
Aug 15 2012 | RDYN | Cardiovascular Sys ... | BETTERLEY LAURENCE L | Chief Financial Off ... | Grant | A | 0.00 | 13,145 | 0 | 172,871 | 159.7 K to 172.9 K (+8.23 %) |
Aug 15 2012 | RDYN | Cardiovascular Sys ... | Flaherty James E | Chief Administrativ ... | Sell | S | 8.92 | 1,271 | 11,335 | 154,915 | 156.2 K to 154.9 K (-0.81 %) |
Aug 15 2012 | RDYN | Cardiovascular Sys ... | Flaherty James E | Chief Administrativ ... | Grant | A | 0.00 | 18,776 | 0 | 156,186 | 137.4 K to 156.2 K (+13.66 %) |
Aug 15 2012 | RDYN | Cardiovascular Sys ... | Flaherty James E | Chief Administrativ ... | Grant | A | 0.00 | 9,388 | 0 | 137,410 | 128 K to 137.4 K (+7.33 %) |
Aug 15 2012 | RDYN | Cardiovascular Sys ... | Flaherty James E | Chief Administrativ ... | Grant | A | 0.00 | 9,388 | 0 | 128,022 | 118.6 K to 128 K (+7.91 %) |
Aug 15 2012 | RDYN | Cardiovascular Sys ... | Kenny Kevin J | Exec. VP, Sales & M ... | Sell | S | 8.92 | 259 | 2,310 | 107,704 | 108 K to 107.7 K (-0.24 %) |
Aug 15 2012 | RDYN | Cardiovascular Sys ... | Kenny Kevin J | Exec. VP, Sales & M ... | Grant | A | 0.00 | 11,820 | 0 | 107,963 | 96.1 K to 108 K (+12.29 %) |
Aug 15 2012 | RDYN | Cardiovascular Sys ... | Kenny Kevin J | Exec. VP, Sales & M ... | Grant | A | 0.00 | 5,911 | 0 | 96,143 | 90.2 K to 96.1 K (+6.55 %) |
Aug 15 2012 | RDYN | Cardiovascular Sys ... | Kenny Kevin J | Exec. VP, Sales & M ... | Grant | A | 0.00 | 5,911 | 0 | 90,232 | 84.3 K to 90.2 K (+7.01 %) |
Aug 15 2012 | RDYN | Cardiovascular Sys ... | Thatcher Robert J | Executive VP | Sell | S | 8.92 | 1,040 | 9,275 | 132,958 | 134 K to 133 K (-0.78 %) |
Aug 15 2012 | RDYN | Cardiovascular Sys ... | Thatcher Robert J | Executive VP | Grant | A | 0.00 | 12,412 | 0 | 133,998 | 121.6 K to 134 K (+10.21 %) |
Aug 15 2012 | RDYN | Cardiovascular Sys ... | Thatcher Robert J | Executive VP | Grant | A | 0.00 | 6,206 | 0 | 121,586 | 115.4 K to 121.6 K (+5.38 %) |
Aug 15 2012 | RDYN | Cardiovascular Sys ... | Thatcher Robert J | Executive VP | Grant | A | 0.00 | 6,206 | 0 | 115,380 | 109.2 K to 115.4 K (+5.68 %) |
Aug 15 2012 | RDYN | Cardiovascular Sys ... | Koehn Paul A | VP Quality & Operat ... | Sell | S | 8.92 | 789 | 7,036 | 73,134 | 73.9 K to 73.1 K (-1.07 %) |
Aug 15 2012 | RDYN | Cardiovascular Sys ... | Koehn Paul A | VP Quality & Operat ... | Grant | A | 0.00 | 11,820 | 0 | 73,923 | 62.1 K to 73.9 K (+19.03 %) |
Aug 15 2012 | RDYN | Cardiovascular Sys ... | Koehn Paul A | VP Quality & Operat ... | Grant | A | 0.00 | 5,911 | 0 | 62,103 | 56.2 K to 62.1 K (+10.52 %) |
Aug 15 2012 | RDYN | Cardiovascular Sys ... | Koehn Paul A | VP Quality & Operat ... | Grant | A | 0.00 | 5,911 | 0 | 56,192 | 50.3 K to 56.2 K (+11.76 %) |
Aug 15 2012 | RDYN | Cardiovascular Sys ... | Martin David | President and CEO | Sell | S | 8.92 | 3,324 | 29,643 | 383,022 | 386.3 K to 383 K (-0.86 %) |
Aug 15 2012 | RDYN | Cardiovascular Sys ... | Martin David | President and CEO | Sell | S | 8.85 | 8,204 | 72,600 | 386,346 | 394.6 K to 386.3 K (-2.08 %) |
Aug 15 2012 | RDYN | Cardiovascular Sys ... | Martin David | President and CEO | Grant | A | 0.00 | 54,584 | 0 | 394,550 | 340 K to 394.6 K (+16.06 %) |
Aug 15 2012 | RDYN | Cardiovascular Sys ... | Martin David | President and CEO | Grant | A | 0.00 | 27,293 | 0 | 339,966 | 312.7 K to 340 K (+8.73 %) |
Aug 15 2012 | RDYN | Cardiovascular Sys ... | Martin David | President and CEO | Grant | A | 0.00 | 27,293 | 0 | 312,673 | 285.4 K to 312.7 K (+9.56 %) |
Jul 19 2012 | RDYN | Cardiovascular Sys ... | Thatcher Robert J | Executive VP | Sell | S | 9.80 | 2,485 | 24,350 | 109,174 | 111.7 K to 109.2 K (-2.23 %) |
Jul 19 2012 | RDYN | Cardiovascular Sys ... | Discovery Group I, LLC | 10% Owner | Sell | S | 10.25 | 514 | 5,271 | 257,242 | 257.8 K to 257.2 K (-0.20 %) |
Jul 19 2012 | RDYN | Cardiovascular Sys ... | Discovery Group I, LLC | 10% Owner | Sell | S | 10.25 | 4,730 | 48,504 | 1,770,416 | 1.8 M to 1.8 M (-0.27 %) |
Jul 19 2012 | RDYN | Cardiovascular Sys ... | Flaherty James E | Chief Administrativ ... | Sell | S | 9.80 | 2,315 | 22,684 | 118,634 | 120.9 K to 118.6 K (-1.91 %) |
Jul 19 2012 | RDYN | Cardiovascular Sys ... | Koehn Paul A | VP Quality & Operat ... | Sell | S | 9.80 | 1,578 | 15,463 | 50,281 | 51.9 K to 50.3 K (-3.04 %) |
Jul 16 2012 | RDYN | Cardiovascular Sys ... | Discovery Group I, LLC | 10% Owner | Sell | S | 10.30 | 408 | 4,202 | 257,756 | 258.2 K to 257.8 K (-0.16 %) |
Jul 16 2012 | RDYN | Cardiovascular Sys ... | Discovery Group I, LLC | 10% Owner | Sell | S | 10.30 | 3,298 | 33,965 | 1,775,146 | 1.8 M to 1.8 M (-0.19 %) |
Jul 16 2012 | RDYN | Cardiovascular Sys ... | Discovery Group I, LLC | 10% Owner | Sell | S | 10.45 | 846 | 8,837 | 258,164 | 259 K to 258.2 K (-0.33 %) |
Jul 16 2012 | RDYN | Cardiovascular Sys ... | Discovery Group I, LLC | 10% Owner | Sell | S | 10.45 | 7,787 | 81,337 | 1,778,444 | 1.8 M to 1.8 M (-0.44 %) |
Jul 16 2012 | RDYN | Cardiovascular Sys ... | Discovery Group I, LLC | 10% Owner | Sell | S | 10.29 | 175 | 1,800 | 259,010 | 259.2 K to 259 K (-0.07 %) |
Jul 16 2012 | RDYN | Cardiovascular Sys ... | Discovery Group I, LLC | 10% Owner | Sell | S | 10.29 | 1,632 | 16,787 | 1,786,231 | 1.8 M to 1.8 M (-0.09 %) |
Jul 19 2012 | RDYN | Cardiovascular Sys ... | BETTERLEY LAURENCE L | Chief Financial Off ... | Sell | S | 9.80 | 3,058 | 29,965 | 159,726 | 162.8 K to 159.7 K (-1.88 %) |
Jul 11 2012 | RDYN | Cardiovascular Sys ... | Discovery Group I, LLC | 10% Owner | Sell | S | 10.26 | 826 | 8,476 | 260,505 | 261.3 K to 260.5 K (-0.32 %) |
Jul 11 2012 | RDYN | Cardiovascular Sys ... | Discovery Group I, LLC | 10% Owner | Sell | S | 10.26 | 7,694 | 78,954 | 1,787,863 | 1.8 M to 1.8 M (-0.43 %) |
Jul 11 2012 | RDYN | Cardiovascular Sys ... | Discovery Group I, LLC | 10% Owner | Sell | S | 10.25 | 970 | 9,943 | 261,331 | 262.3 K to 261.3 K (-0.37 %) |
Jul 11 2012 | RDYN | Cardiovascular Sys ... | Discovery Group I, LLC | 10% Owner | Sell | S | 10.25 | 9,030 | 92,559 | 1,795,557 | 1.8 M to 1.8 M (-0.50 %) |
Jul 11 2012 | RDYN | Cardiovascular Sys ... | Discovery Group I, LLC | 10% Owner | Sell | S | 10.34 | 660 | 6,826 | 262,301 | 263 K to 262.3 K (-0.25 %) |
Jul 11 2012 | RDYN | Cardiovascular Sys ... | Discovery Group I, LLC | 10% Owner | Sell | S | 10.34 | 6,440 | 66,604 | 1,804,587 | 1.8 M to 1.8 M (-0.36 %) |
May 31 2012 | RDYN | Cardiovascular Sys ... | Kenny Kevin J | Exec. VP, Sales & M ... | Payment of Exercise | F | 9.34 | 7,771 | 72,612 | 84,321 | 92.1 K to 84.3 K (-8.44 %) |
Feb 28 2012 | RDYN | Cardiovascular Sys ... | Martin David | President and CEO | Sell | S | 9.30 | 9,000 | 83,732 | 285,380 | 294.4 K to 285.4 K (-3.06 %) |
Feb 28 2012 | RDYN | Cardiovascular Sys ... | Martin David | President and CEO | Gift | G | 0.00 | 1,600 | 0 | 294,380 | 296 K to 294.4 K (-0.54 %) |
Feb 17 2012 | RDYN | Cardiovascular Sys ... | NELSON GLEN D | Director | Buy | P | 8.71 | 5,000 | 43,546 | 382,775 | 377.8 K to 382.8 K (+1.32 %) |
Feb 17 2012 | RDYN | Cardiovascular Sys ... | FRIEDMAN JOHN H | Director | Sell | S | 8.75 | 5,853 | 51,218 | 0 | 5.9 K to 0 (-100.00 %) |
Feb 17 2012 | RDYN | Cardiovascular Sys ... | FRIEDMAN JOHN H | Director | Sell | S | 8.69 | 52,972 | 460,343 | 5,853 | 58.8 K to 5.9 K (-90.05 %) |
Feb 17 2012 | RDYN | Cardiovascular Sys ... | FRIEDMAN JOHN H | Director | Sell | S | 8.82 | 6,850 | 60,424 | 58,825 | 65.7 K to 58.8 K (-10.43 %) |
Feb 14 2012 | RDYN | Cardiovascular Sys ... | NELSON GLEN D | Director | Buy | P | 8.93 | 10,000 | 89,257 | 377,775 | 367.8 K to 377.8 K (+2.72 %) |
Feb 14 2012 | RDYN | Cardiovascular Sys ... | NELSON GLEN D | Director | Buy | P | 8.92 | 30,000 | 267,603 | 367,775 | 337.8 K to 367.8 K (+8.88 %) |
Feb 01 2012 | RDYN | Cardiovascular Sys ... | FRIEDMAN JOHN H | Director | Sell | S | 9.18 | 5,796 | 53,189 | 65,675 | 71.5 K to 65.7 K (-8.11 %) |
Feb 01 2012 | RDYN | Cardiovascular Sys ... | FRIEDMAN JOHN H | Director | Sell | S | 9.20 | 18,263 | 168,104 | 71,471 | 89.7 K to 71.5 K (-20.35 %) |
Feb 01 2012 | RDYN | Cardiovascular Sys ... | FRIEDMAN JOHN H | Director | Sell | S | 9.24 | 29,932 | 276,706 | 89,734 | 119.7 K to 89.7 K (-25.01 %) |
Jan 27 2012 | RDYN | Cardiovascular Sys ... | FRIEDMAN JOHN H | Director | Sell | S | 9.67 | 11,738 | 113,456 | 119,666 | 131.4 K to 119.7 K (-8.93 %) |
Jan 27 2012 | RDYN | Cardiovascular Sys ... | FRIEDMAN JOHN H | Director | Sell | S | 9.76 | 21,355 | 208,512 | 131,404 | 152.8 K to 131.4 K (-13.98 %) |
Jan 27 2012 | RDYN | Cardiovascular Sys ... | FRIEDMAN JOHN H | Director | Sell | S | 9.68 | 28,429 | 275,153 | 152,759 | 181.2 K to 152.8 K (-15.69 %) |
Jan 24 2012 | RDYN | Cardiovascular Sys ... | FRIEDMAN JOHN H | Director | Sell | S | 9.62 | 31,240 | 300,429 | 181,188 | 212.4 K to 181.2 K (-14.71 %) |
Jan 24 2012 | RDYN | Cardiovascular Sys ... | FRIEDMAN JOHN H | Director | Sell | S | 10.00 | 3,500 | 34,995 | 212,428 | 215.9 K to 212.4 K (-1.62 %) |
Jan 24 2012 | RDYN | Cardiovascular Sys ... | FRIEDMAN JOHN H | Director | Sell | S | 10.00 | 9,773 | 97,758 | 215,928 | 225.7 K to 215.9 K (-4.33 %) |
Jan 20 2012 | RDYN | Cardiovascular Sys ... | FRIEDMAN JOHN H | Director | Sell | S | 10.07 | 8,300 | 83,606 | 225,701 | 234 K to 225.7 K (-3.55 %) |
Jan 20 2012 | RDYN | Cardiovascular Sys ... | FRIEDMAN JOHN H | Director | Sell | S | 9.92 | 18,200 | 180,540 | 234,001 | 252.2 K to 234 K (-7.22 %) |
Jan 19 2012 | RDYN | Cardiovascular Sys ... | Flaherty James E | Chief Administrativ ... | Sell | S | 10.01 | 5,000 | 50,058 | 119,638 | 124.6 K to 119.6 K (-4.01 %) |
Jan 17 2012 | RDYN | Cardiovascular Sys ... | FRIEDMAN JOHN H | Director | Sell | S | 10.20 | 5,900 | 60,188 | 252,201 | 258.1 K to 252.2 K (-2.29 %) |
Jan 17 2012 | RDYN | Cardiovascular Sys ... | FRIEDMAN JOHN H | Director | Sell | S | 10.33 | 6,000 | 62,002 | 258,101 | 264.1 K to 258.1 K (-2.27 %) |
Jan 13 2012 | RDYN | Cardiovascular Sys ... | FRIEDMAN JOHN H | Director | Sell | S | 10.42 | 8,700 | 90,637 | 264,101 | 272.8 K to 264.1 K (-3.19 %) |
Jan 13 2012 | RDYN | Cardiovascular Sys ... | FRIEDMAN JOHN H | Director | Sell | S | 10.44 | 8,832 | 92,212 | 272,801 | 281.6 K to 272.8 K (-3.14 %) |
Jan 11 2012 | RDYN | Cardiovascular Sys ... | FRIEDMAN JOHN H | Director | Sell | S | 10.43 | 13,500 | 140,819 | 281,633 | 295.1 K to 281.6 K (-4.57 %) |
Jan 11 2012 | RDYN | Cardiovascular Sys ... | FRIEDMAN JOHN H | Director | Sell | S | 10.41 | 13,500 | 140,489 | 295,133 | 308.6 K to 295.1 K (-4.37 %) |
Jan 09 2012 | RDYN | Cardiovascular Sys ... | FRIEDMAN JOHN H | Director | Sell | S | 10.42 | 12,557 | 130,854 | 308,633 | 321.2 K to 308.6 K (-3.91 %) |
Jan 09 2012 | RDYN | Cardiovascular Sys ... | FRIEDMAN JOHN H | Director | Sell | S | 10.41 | 22,435 | 233,436 | 321,190 | 343.6 K to 321.2 K (-6.53 %) |
Jan 05 2012 | RDYN | Cardiovascular Sys ... | FRIEDMAN JOHN H | Director | Sell | S | 10.25 | 20,543 | 210,533 | 343,625 | 364.2 K to 343.6 K (-5.64 %) |
Jan 05 2012 | RDYN | Cardiovascular Sys ... | FRIEDMAN JOHN H | Director | Sell | S | 10.11 | 31,855 | 322,089 | 364,168 | 396 K to 364.2 K (-8.04 %) |
Nov 30 2011 | RDYN | Cardiovascular Sys ... | FRIEDMAN JOHN H | Director | Sell | S | 10.00 | 14,700 | 146,947 | 396,023 | 410.7 K to 396 K (-3.58 %) |
Nov 30 2011 | RDYN | Cardiovascular Sys ... | FRIEDMAN JOHN H | Director | Sell | S | 10.04 | 10,300 | 103,375 | 410,723 | 421 K to 410.7 K (-2.45 %) |
Nov 28 2011 | RDYN | Cardiovascular Sys ... | NELSON GLEN D | Director | Buy | P | 9.45 | 10,000 | 94,530 | 337,775 | 327.8 K to 337.8 K (+3.05 %) |
Nov 18 2011 | RDYN | Cardiovascular Sys ... | Brown Edward M | Director | Sell | S | 9.59 | 5,000 | 47,969 | 70,102 | 75.1 K to 70.1 K (-6.66 %) |
Nov 16 2011 | RDYN | Cardiovascular Sys ... | Brown Edward M | Director | Sell | S | 9.30 | 5,000 | 46,494 | 75,102 | 80.1 K to 75.1 K (-6.24 %) |
Nov 16 2011 | RDYN | Cardiovascular Sys ... | Brown Edward M | Director | Sell | S | 9.51 | 4,000 | 38,025 | 80,102 | 84.1 K to 80.1 K (-4.76 %) |
Nov 16 2011 | RDYN | Cardiovascular Sys ... | NELSON GLEN D | Director | Buy | P | 9.37 | 10,500 | 98,362 | 327,775 | 317.3 K to 327.8 K (+3.31 %) |
Nov 16 2011 | RDYN | Cardiovascular Sys ... | NELSON GLEN D | Director | Buy | P | 9.53 | 10,300 | 98,194 | 317,275 | 307 K to 317.3 K (+3.36 %) |